Design of a decision support system to help clinicians manage glycemia in patients with type 2 diabetes mellitus

Journal of Diabetes Science and Technology

Volumn 5, Issue 2, 2011, Pages 402-411

  Rodbard, David ^a   Vigersky, Robert A ^b  

^a Biomedical Informatics Consultants LLC   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Algorithm; Artificial intelligence; Clinical decision support; Clinical diabetes; Expert system; Insulin; Oral anti diabetic agents; Type 2 diabetes mellitus

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA;

ARTICLE; CLINICAL DECISION SUPPORT SYSTEM; DECISION SUPPORT SYSTEM; DIET; ELECTRONIC MEDICAL RECORD; EXERCISE; EXPERT SYSTEM; FOOD AND DRUG ADMINISTRATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN INFUSION; INSULIN TREATMENT; INTERNET; LIFESTYLE MODIFICATION; MEDICAL HISTORY; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; SELF MONITORING; ALGORITHM; BLOOD; COMPUTER PROGRAM; FEMALE; MALE; ORAL DRUG ADMINISTRATION; STATISTICAL MODEL;

ADMINISTRATION, ORAL; ALGORITHMS; BLOOD GLUCOSE; DECISION SUPPORT SYSTEMS, CLINICAL; DECISION SUPPORT TECHNIQUES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERGLYCEMIA; INSULIN; MALE; METFORMIN; MODELS, STATISTICAL; SOFTWARE;

EID: 80053419520     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681100500230     Document Type: Article

References (45)

1. Albisser AM. Six generations of the insulin dosage computer: a new clinical device for diabetes self-management through specialized centres. Horm Metab Res Suppl. 1990;24:140-4.
2. Chiarelli F, Tumini S, Morgese G, Albisser AM. Controlled study in diabetic children comparing insulin-dosage adjustment by manual and computer algorithms. Diabetes Care. 1990;13(10):1080-4.
3. Chanoch LH, Jovanovic L, Peterson CM. The evaluation of a pocket computer as an aid to insulin dose determination by patients. Diabetes Care. 1985;8(2):172-6.
4. Gross TM, Kayne D, King A, Rother C, Juth S. A bolus calculator is an effective means of controlling postprandial glycemia in patients on insulin pump therapy. Diabetes Technol Ther. 2003;5(3):365-9.
5. Davidson PC, Steed RD, Bode BW. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care. 2005;28(10):2418-23.
6. Pernick NL, Rodbard D. Personal computer programs to assist with self-monitoring of blood glucose and self-adjustment of insulin dosage. Diabetes Care. 1986;9(1):61-9.
7. Mazze RS, Etzwiler DD, Strock E, Peterson K, McClave CR 2nd, Meszaros JF, Leigh C, Owens LW, Deeb LC, Peterson A. Staged diabetes management. Toward an integrated model of diabetes care. Diabetes Care. 1994;17 Suppl 1:56-66.
8. Mazze RS, Strock ES, Simonson GD, Bergenstal RM. Staged diabetes management: a systematic approach (revised second edition). Wiley; New York: 2007. http://media.wiley.com/product-data/excerpt/6X/04700612/047006126X.pdf.
9. Osheroff JA, Teich JM, Middleton B, Steen EB, Wright A, Detmer DE. A roadmap for national action on clinical decision support. J Am Med Inform Assoc. 2007;14(2):141-5.
10. Yu VL, Buchanan BG, Shortliffe EH, Wraith SM, Davis R, Scott AC, Cohen SN. Evaluating the performance of a computer-based consultant. Comput Programs Biomed. 1979;9(1):95-102.
11. Evans RS, Pestotnik SL, Classen DC, Clemmer TP, Weaver LK, Orme JF Jr, Lloyd JF, Burke JP. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med. 1998;338(4):232-8.
12. Langlotz CP, Fagan LM, Tu SW, Sikic BI, Shortliffe EH. A therapy planning architecture that combines decision theory and artificial intelligence techniques. Comput Biomed Res. 1987;20(3):279-303.
13. Rocha BH, Langford LH, Towner S. Computerized management of chronic anticoagulation: three years of experience. Stud Health Technol Inform. 2007;129(Pt 2):1032-6.
14. Kelly JJ, Sweigard KW, Shields K, Schneider D, Eisenberg JM. Patient Safety Awards. Safety, effectiveness, and efficiency: a Web-based virtual anticoagulation clinic. Jt Comm J Qual Saf. 2003;29(12):646-51.
15. Schedlbauer A, Prasad V, Mulvaney C, Phansalkar S, Stanton W, Bates DW, Avery AJ. What evidence supports the use of computerized alerts and prompts to improve clinicians' prescribing behavior? J Am Med Inform Assoc. 2009;16(4):531-8.
16. Tierney WM, Overhage JM, Takesue BY, Harris LE, Murray MD, Vargo DL, McDonald CJ. Computerizing guidelines to improve care and patient outcomes: the example of heart failure. J Am Med Inform Assoc. 1995;2(5):316-22.
17. Tierney WM, Overhage JM, Murray MD, Harris LE, Zhou XH, Eckert GJ, Smith FE, Nienaber N, McDonald CJ, Wolinsky FD. Effects of computerized guidelines for managing heart disease in primary care. J Gen Intern Med. 2003;18(12):967-76.
18. Tierney WM, Overhage JM, Murray MD, Harris LE, Zhou XH, Eckert GJ, Smith FE, Nienaber N, McDonald CJ, Wolinsky FD. Can computer-generated evidence-based care suggestions enhance evidence-based management of asthma and chronic obstructive pulmonary disease? A randomized, controlled trial. Health Serv Res. 2005;40(2):477-97.
19. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291(3):335-42.
20. Grant RW, Cagliero E, Dubey AK, Gildesgame C, Chueh HC, Barry MJ, Singer DE, Nathan DM, Meigs JB. Clinical inertia in the management of type 2 diabetes metabolic risk factors. Diabet Med. 2004;21(2):150-5.
21. Grant RW, Buse JB, Meigs JB, University HealthSystem Consortium (UHC) Diabetes Benchmarking Project Team. Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care. 2005;28(2):337-442.
22. Rodbard HW, Fox KM, Hardy E, Grandy S, SHIELD Study Group. Disease control among adults with type 2 diabetes mellitus, hypertension and obesity. Abstract from the Annual Meeting of American Association of Clinical Endocrinologists, Boston, MA, 2010.
23. Rizza RA, Vigersky RA, Rodbard HW, Ladenson PW, Young WF Jr, Surks MI, Kahn R, Hogan PF. A model to determine workforce needs for endocrinologists in the United States until 2020. Endocr Pract. 2003;9(3):210-9.
24. Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P, Moghissi ES, Schwartz SS. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract. 2009;15(6):540-59.
25. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, American Diabetes Association, European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193-203.
26. Woo V. Important differences: Canadian Diabetes Association 2008 clinical practice guidelines and the consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2009;52(3):552-5.
27. Inzucchi SE. Diabetes facts and guidelines. Accessed August 28, 2010. http://medicine.yale.edu/intmed/endocrin/Images/695-21366-Takeda-Yale-KLL- tcm314-50135.PDF.
28. Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, Hellman R, Jellinger PS, Jovanovic LG, Levy P, Mechanick JI, Zangeneh F, AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;13 Suppl 1:1-68.
29. Buse JB, Bergenstal RM, Glass LC, Heilmann CR, Lewis MS, Kwan AY, Hoogwerf BJ, Rosenstock J. Use of twice-daily exenatide in basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial. Ann Intern Med. 2011;154(2):103-12.
30. Rodbard D. Optimizing display, analysis, interpretation and utility of self-monitoring of blood glucose (SMBG) data for management of patients with diabetes. J Diabetes Sci Technol. 2007;1(1): 62-71.
31. Polonsky WH, Jelsovsky Z, Panzera S, Parkin CG, Wagner RS. Primary care physicians identify and act upon glycemic abnormalities found in structured, episodic blood glucose monitoring data from non-insulin-treated type 2 diabetes. Diabetes Technol Ther. 2009;11(5):283-91.
32. Fonda SJ, Paulsen CA, Perkins J, Kedziora RJ, Rodbard D, Bursell SE. Usability test of an internet-based informatics tool for diabetes care providers: the comprehensive diabetes management program. Diabetes Technol Ther. 2008;10(1):16-24.
33. Rodbard D. Display of glucose distributions by date, time of day, and day of week: new and improved methods. J Diabetes Sci Technol. 2009 Nov 1;3(6):1388-94.
34. Rodbard D. A semilogarithmic scale for glucose provides a balanced view of hyperglycemia and hypoglycemia. J Diabetes Sci Technol. 2009;3(6):1395-401.
35. Mazze RS, Lucido D, Langer O, Hartmann K, Rodbard D. Ambulatory glucose profile: representation of verified selfmonitored blood glucose data. Diabetes Care. 1987;10(1):111-7.
36. Mazze RS, Strock E, Wesley D, Borgman S, Morgan B, Bergenstal R, Cuddihy R. Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technol Ther. 2008;10(3):149-59.
37. Rodbard D. New approaches to display of self-monitoring of blood glucose data. J Diabetes Sci Technol. 2009;3(5):1121-7.
38. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ, A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473-8.
39. Rodbard D, Vigersky R. Development of algorithms for clinical decision support for primary care providers. Diabetes Technol Ther. 2005;7(2):409.
40. Vigersky RA, Galen RS, Horne D, Cavotta M, Rodbard D. Computer assisted decision support (CADS) for primary care of diabetes. Telemed E-Health. 2007;13:168.
41. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD, VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129-39.
42. Rodbard, D. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther. 2009;11 Suppl 1:S55-67.
43. Rodbard D. New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther. 2009;11(9):551-65.
44. Skyler JS, Skyler DL, Seigler DE, O'Sullivan MJ. Algorithms for adjustment of insulin dosage by patients who monitor blood glucose. Diabetes Care. 1981;4(2):311-8.
45. Schade DS, Santiago JV, Skyler JS, Rizza RA. Intensive insulin therapy. Amsterdam: Excerpta Medica; 1983.